248 related articles for article (PubMed ID: 33305533)
1. Chemotherapy triggers cachexia by deregulating synergetic function of histone-modifying enzymes.
Amrute-Nayak M; Pegoli G; Holler T; Lopez-Davila AJ; Lanzuolo C; Nayak A
J Cachexia Sarcopenia Muscle; 2021 Feb; 12(1):159-176. PubMed ID: 33305533
[TBL] [Abstract][Full Text] [Related]
2. Regulation of SETD7 Methyltransferase by SENP3 Is Crucial for Sarcomere Organization and Cachexia.
Nayak A; Lopez-Davila AJ; Kefalakes E; Holler T; Kraft T; Amrute-Nayak M
Cell Rep; 2019 May; 27(9):2725-2736.e4. PubMed ID: 31141694
[TBL] [Abstract][Full Text] [Related]
3. SENP7 deSUMOylase-governed transcriptional program coordinates sarcomere assembly and is targeted in muscle atrophy.
Amrute-Nayak M; Gand LV; Khan B; Holler T; Kefalakes E; Kosanke M; Kraft T; Nayak A
Cell Rep; 2022 Nov; 41(8):111702. PubMed ID: 36417853
[TBL] [Abstract][Full Text] [Related]
4. Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1.
He Z; Song Q; Yu Y; Liu F; Zhao J; Un W; Da X; Xu C; Yao Y; Wang QK
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):978-991. PubMed ID: 36696895
[TBL] [Abstract][Full Text] [Related]
5. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
7. Triptolide prevents LPS-induced skeletal muscle atrophy via inhibiting NF-κB/TNF-α and regulating protein synthesis/degradation pathway.
Fang WY; Tseng YT; Lee TY; Fu YC; Chang WH; Lo WW; Lin CL; Lo YC
Br J Pharmacol; 2021 Aug; 178(15):2998-3016. PubMed ID: 33788266
[TBL] [Abstract][Full Text] [Related]
8. The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy.
Proserpio V; Fittipaldi R; Ryall JG; Sartorelli V; Caretti G
Genes Dev; 2013 Jun; 27(11):1299-312. PubMed ID: 23752591
[TBL] [Abstract][Full Text] [Related]
9. IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway.
Liu D; Qiao X; Ge Z; Shang Y; Li Y; Wang W; Chen M; Si S; Chen SZ
Skelet Muscle; 2019 Mar; 9(1):8. PubMed ID: 30922397
[TBL] [Abstract][Full Text] [Related]
10. Cancer-Induced Muscle Wasting Requires p38β MAPK Activation of p300.
Sin TK; Zhang G; Zhang Z; Zhu JZ; Zuo Y; Frost JA; Li M; Li YP
Cancer Res; 2021 Feb; 81(4):885-897. PubMed ID: 33355181
[TBL] [Abstract][Full Text] [Related]
11. Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia.
Bowen TS; Adams V; Werner S; Fischer T; Vinke P; Brogger MN; Mangner N; Linke A; Sehr P; Lewis J; Labeit D; Gasch A; Labeit S
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):939-953. PubMed ID: 28887874
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
Reed SA; Sandesara PB; Senf SM; Judge AR
FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
[TBL] [Abstract][Full Text] [Related]
13. Electrical stimulation prevents doxorubicin-induced atrophy and mitochondrial loss in cultured myotubes.
Guigni BA; Fix DK; Bivona JJ; Palmer BM; Carson JA; Toth MJ
Am J Physiol Cell Physiol; 2019 Dec; 317(6):C1213-C1228. PubMed ID: 31532714
[TBL] [Abstract][Full Text] [Related]
14. α-Hydroxyisocaproic Acid Decreases Protein Synthesis but Attenuates TNFα/IFNγ Co-Exposure-Induced Protein Degradation and Myotube Atrophy via Suppression of iNOS and IL-6 in Murine C2C12 Myotube.
Sumi K; Sakuda M; Munakata K; Nakamura K; Ashida K
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371902
[TBL] [Abstract][Full Text] [Related]
15. C/EBPβ promotes the expression of atrophy-inducing factors by tumours and is a central regulator of cancer cachexia.
AlSudais H; Rajgara R; Saleh A; Wiper-Bergeron N
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):743-757. PubMed ID: 35014202
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Models for Studying the Impact of Macrophages on Cancer Cachexia.
Markov SD; Gonzalez D; Mehla K
Curr Protoc Pharmacol; 2020 Dec; 91(1):e80. PubMed ID: 33264501
[TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle atrophy and dysfunction in breast cancer patients: role for chemotherapy-derived oxidant stress.
Guigni BA; Callahan DM; Tourville TW; Miller MS; Fiske B; Voigt T; Korwin-Mihavics B; Anathy V; Dittus K; Toth MJ
Am J Physiol Cell Physiol; 2018 Nov; 315(5):C744-C756. PubMed ID: 30207784
[TBL] [Abstract][Full Text] [Related]
18. Multiple muscle wasting-related transcription factors are acetylated in dexamethasone-treated muscle cells.
Chamberlain W; Gonnella P; Alamdari N; Aversa Z; Hasselgren PO
Biochem Cell Biol; 2012 Apr; 90(2):200-8. PubMed ID: 22292478
[TBL] [Abstract][Full Text] [Related]
19. SETD7 Drives Cardiac Lineage Commitment through Stage-Specific Transcriptional Activation.
Lee J; Shao NY; Paik DT; Wu H; Guo H; Termglinchan V; Churko JM; Kim Y; Kitani T; Zhao MT; Zhang Y; Wilson KD; Karakikes I; Snyder MP; Wu JC
Cell Stem Cell; 2018 Mar; 22(3):428-444.e5. PubMed ID: 29499155
[TBL] [Abstract][Full Text] [Related]
20. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
